Table 2.

Reason for hospitalization during the first 24 months of follow-up by intervention group: the LIFE study

Total inpatient hospitalizations*	Physical activity (n=299)	Health education (n=247)	p-value
	n (%)
Blood and lymphatic systems disorders	3 (1.0)	3 (1.2)	0.81
Cardiac disorders	53 (17.7)	41 (16.6)	0.73
Ear and Labyrinth disorders	2 (0.7)	3 (1.2)	0.51
Endocrine disorders	3 (1.0)	0 (0.0)	0.11
Eye disorders	0 (0.0)	1 (0.4)	0.27
Gastrointestinal disorders	34 (11.4)	19 (7.7)	0.15
General disorders/administration site conditions	8 (2.7)	6 (2.4)	0.86
Hepatobiliary disorders	4 (1.3)	2 (0.8)	0.56
Immune system disorders	3 (1.0)	0 (0.0)	0.11
Infections and infestations	28 (9.4)	17 (6.9)	0.29
Injury, poisoning, and procedural complications	22 (7.4)	18 (7.3)	0.98
Investigations	0 (0.0)	1 (0.4)	0.27
Metabolism and nutrition disorders	10 (3.3)	6 (2.4)	0.53
Musculoskeletal and connective tissue disorders	19 (6.4)	25 (10.1)	0.11
Neoplasms: benign, malignant, and unspecified	4 (1.3)	2 (0.8)	0.56
Nervous system disorders	29 (9.7)	21 (8.5)	0.63
Psychiatric disorders	1 (0.3)	1 (0.4)	0.89
Renal and urinary disorders	5 (1.7)	8 (3.2)	0.23
Reproductive system and breast disorders	2 (0.7)	2 (0.8)	0.85
Respiratory, thoracic, and mediastinal disorder	16 (5.4)	16 (6.5)	0.58
Skin and subcutaneous tissue disorders	0 (0.0)	4 (1.6)	0.03
Surgical and medical procedures	38 (12.7)	38 (15.4)	0.37
Vascular disorders	15 (5.0)	13 (5.3)	0.90

^*Based on Medical Dictionary for Regulatory Activities (MedDRA) system organ class, listed in alphabetical order

P-values were derived using chi-squared tests for each hospitalization class